Latest Earnings Results: Q1 '27
Estimated EPS
$2.69
Reported EPS
$2.91
Surprise
+8.33%
Estimated Rev
$1.39B
Reported Rev
$1.41B
Surprise
+1.47%
• Reported GAAP EPS of $2.91 up 14.12% YoY • Reported revenue of $1.41B up 5.93% YoY • Resmed maintained FY 2027 guidance, unchanged from August 6, 2026: core constant currency revenue growth of 57%, reported revenue of $5.75B, and non-GAAP diluted EPS of $12.00$12.25.
Generated by Stocktwits using AI and company-reported earnings data for Q1 '27. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q2 '27 | $2.99 | -- | -- | N/A |
Q1 '27 | $2.69 | $2.91 | 8.33% | BEAT |
Q4 '26 | $2.89 | $2.95 | 1.98% | BEAT |
Q3 '26 | $2.80 | $2.86 | 2.32% | BEAT |
Q2 '26 | $2.74 | $2.81 | 2.73% | BEAT |